8-K ·Filed Oct 22, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Board additions are routine governance events with no immediate trading implications. Monitor future filings for any strategic shifts or operational updates tied to the new directors.
Latest settled — T+1d
EAIQ ▲ 0.00% at T+1d
NEUTRAL call 0.00% · α vs SPY +0.52% · entry $1.25 → $1.25
T+1d
0.00%
call 0.00% · α +0.52%
$1.25
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Eyeonix AIQ, Inc. added Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors effective October 16, 2026, following an Extraordinary Meeting of the Board. This is a routine governance filing with no financial data or red flags.
Key Facts
- Dr. Rohit Chitale and Dr. Grigoris Gerotziafas appointed to the board of directors
- Appointment effective October 16, 2026
- No departures, resignations, or compensation details disclosed
Financial Impact
No financial impact disclosed
Risk Factors
- No material risks identified from this filing
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171520-26-000313 |
| Document: 0001171520-26-000313-index-headers.html | 0001171520-26-000313 |
| Document: 0001171520-26-000313-index.html | 0001171520-26-000313 |
| Document: 0001171520-26-000313.txt | 0001171520-26-000313 |
US Market Status
Market Closed — Opens in 59m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers